lobbying_activities: 2774350
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2774350 | 0842717a-c2e0-4289-8549-5c05d43cb39d | Q1 | DESIMONE CONSULTING, LLC | 400931695 | WE WORK FOR HEALTH | 2022 | first_quarter | MED | Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry; PDUFA Reauthorization; FY2022 Budget Reconciliation (H.R.5376). | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2022-04-14T15:36:00-04:00 |